Search results
10 lip 2024 · A high-level overview of Walgreens Boots Alliance, Inc. (WBA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
27 cze 2024 · DEERFIELD, Ill.--(BUSINESS WIRE)--Jun. 27, 2024-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter of fiscal 2024, which ended May 31, 2024. Chief Executive Officer Tim Wentworth said:
4 dni temu · Walgreens Boots Alliance, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: WBA | Nasdaq.
10 lip 2024 · DEERFIELD, Ill. -- JULY 10, 2024 -- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on Sept. 12, 2024, to stockholders of record as of Aug. 21, 2024.
10 lip 2024 · DEERFIELD, Ill., July 10, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of William H. Shrank, M.D., to the company’s board of directors. Dr. Shrank is ...
3 lip 2024 · Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%).
10 lip 2024 · DEERFIELD, Ill. -- (BUSINESS WIRE)--Jul. 10, 2024-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of William H. Shrank, M.D., to the company’s board of directors. Dr. Shrank is globally recognized for his leadership and expertise in healthcare strategy, policy and population health.
